Monrovia, CA, United States of America

David F Carmichael

USPTO Granted Patents = 4 



Average Co-Inventor Count = 6.5

ph-index = 4

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2010-2017

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: David F. Carmichael: Innovator in Antibody Engineering

Introduction

David F. Carmichael is a prominent inventor based in Monrovia, CA (US). He has made significant contributions to the field of antibody engineering, holding a total of 4 patents. His work focuses on optimizing antibodies for enhanced therapeutic applications.

Latest Patents

Among his latest patents is the development of optimized anti-CD30 antibodies. This invention targets CD30, featuring modifications that allow the antibody to bind with altered affinity to an FcγR or to change effector function compared to the parent antibody. Additionally, methods for utilizing this anti-CD30 antibody are disclosed. Another notable patent involves modified Fc molecules, which relates to Fc variants with optimized Fc receptor binding properties. This patent includes methods for generating these variants, Fc polypeptides comprising the optimized Fc variants, and methods for their application.

Career Highlights

David F. Carmichael is currently associated with Xencor, Inc., a company known for its innovative approaches in biopharmaceuticals. His work at Xencor has positioned him as a key player in the advancement of antibody therapies.

Collaborations

Throughout his career, David has collaborated with notable colleagues, including John R. Desjarlais and Sher Bahadur Karki. These collaborations have further enriched his research and development efforts in the field.

Conclusion

David F. Carmichael's contributions to antibody engineering are noteworthy, with a focus on optimizing therapeutic antibodies for better efficacy. His innovative patents and collaborations continue to influence the landscape of biopharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…